Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 86 for “"Proinsulin"”.
-
Removing, replacing, and processing proinsulin in beta-cells
… leading to secretion of insulin’s precursor proinsulin. We created adult insulin knockout mice using AAV Ins1-Cre and failed to prevent onset of diabetes with AAV Ins1-Ins1. Finally, in Chapter 5 we assessed the production of mature insulin in human β-cells. Despite consensus on the role of …
-
RUNDC1 Regulates Proinsulin/Insulin Trafficking and TGN Exit
… mechanisms controlling the kinetic efficacy of proinsulin export at the TGN. Herein, we have identified RUNDC1, a highly conserved member of the RUN domain family of proteins, as a major factor in regulating proinsulin trafficking in pancreatic β cells. Through RNA interference mediated …
-
Human Proinsulin and Insulin: Antibody Production, Assay Development and Clinical Application
… were produced using porcine insulin and human proinsulin as immunogens. Six reacted with insulin and proinsulin, one with C-peptide and proinsulin, and three with proinsulin only (Chapter 4). The detection of McAbs specific for proinsulin required the preparation of monoiodinated …
-
Studies on the development of assay methods for the measurement of proinsulin
… to develop methods for measurement of proinsulin in various metabolic conditions. Imtally, this project focussed on the use of rat hepatocytes as a model system for investigating the effect of proinsulin on 3-hydroxy-3-methylglutaryl coenzyme. A reductase, the rate limiting enzyme …
-
Mass spectrometric characterization of zinc activated proinsulin C-peptide and C-peptide mutants
Thesis (M. S.)--Michigan State University. Chemistry, 2009
-
Study of the expression of proinsulin as a biopolymer fusion protein in transgenic systems
Master of Science (M.S.)
-
Optimization of Refolding, Purification, and Analytical Characterization of Proinsulin(F25D) Soluble Antigen Array Immunotherapy
… immune responses to insulin and its precursor, proinsulin. Soluble antigen arrays (SAgAs) displaying the metabolically inactive proinsulin variant, proinsulin(F25D), represent a promising antigen‑specific immunotherapy candidate for T1D. However, the production of these platforms is hindered by …
-
Chromosomal localization of a proinsulin transgene inserted with a transposon-based vector into Japanese quail, Coturnix coturnix
… ƒÝm samples, and chromosomal identification of proinsulin transgene insertions by laser microdissection and nucleotide sequence from G2 Japanese quail. The 28S rDNA was found on a macrochromosome and a microchromosome pair by primed in situ hybridization, fluorescent in situ hybridization, and …
-
Investigations into the mechanism of cyproheptadine-induced inhibition of proinsulin biosynthesis and depletion of pancreatic insulin content
Thesis (Ph.D.)--Michigan State University. Department of Pharmacology and Toxicology, 1990
-
Low Cost Production Of Proinsulin In Tobacco And Lettuce Chloroplasts For Injectable Or Oral Delivery Of Functional Insulin And
… expensive. The production of chloroplast-derived proinsulin should reduce cost and facilitate oral delivery. Therefore, tobacco and lettuce chloroplasts were transformed with the cholera toxin B subunit fused with human proinsulin (A, B, and C peptides) containing three furin cleavage sites …
-
Prohormone processing in pancreatic islet transplantation
… associated with amyloid formation, and defective proinsulin processing resulting in disproportionate secretion of intact proinsulin and proinsulin intermediates. We hypothesized that processing of the beta-cell prohormones, proinsulin and pro-islet amyloid polypeptide (proIAPP), will be impaired …
-
Mechanisms of action of peptide immunotherapy for Type 1 diabetes: Characterising T-cells induced or modified by proinsulin C19-A3
… diabetes. The safety and mechanistic effects of proinsulin C198A3 (PI C198A3), a HLA8DR4 restricted, naturally processed and presented peptide, was assessed through a multicentre placebo controlled double8blind clinical trial of 2 or 4 weekly intradermal doses of 10µg peptide for 6 months, with a …
Page 1 of 5